A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus
Clinical trial NCT02465580 · UNKNOWN
Trial details
- NCT number
- NCT02465580
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.